Perfluorooctane Sulfonate Concentrations in Amniotic Fluid, Biomarkers of Fetal Leydig Cell Function, and Cryptorchidism and Hypospadias in Danish Boys (1980–1996) | Zendy

Gunnar Toft | Zendy; Bo Jönsson | Zendy; Jens Peter Bonde | Zendy; Bent NørgaardPedersen | Zendy; David M. Hougaard | Zendy; Arieh S. Cohen | Zendy; Christian Lindh | Zendy; Richard Ivell | Zendy; Ravinder AnandIvell | Zendy; Morten Søndergaard Lindhard | Zendy

Open Access

Perfluorooctane Sulfonate Concentrations in Amniotic Fluid, Biomarkers of Fetal Leydig Cell Function, and Cryptorchidism and Hypospadias in Danish Boys (1980–1996)

Author(s) -

Gunnar Toft,

Bo Jönsson,

Jens Peter Bonde,

Bent NørgaardPedersen,

David M. Hougaard,

Arieh S. Cohen,

Christian Lindh,

Richard Ivell,

Ravinder AnandIvell,

Morten Søndergaard Lindhard

Publication year - 2015

Publication title -

environmental health perspectives

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.257

H-Index - 282

eISSN - 1552-9924

pISSN - 0091-6765

DOI - 10.1289/ehp.1409288

Subject(s) - amniotic fluid , hypospadias , perfluorooctane , testosterone (patch) , medicine , hormone , anogenital distance , pregnancy , endocrinology , leydig cell , population , fetus , andrology , physiology , obstetrics , gynecology , chemistry , luteinizing hormone , biology , in utero , surgery , sulfonate , genetics , environmental health , organic chemistry , sodium

Exposure to perfluorooctane sulfonate (PFOS) may potentially disturb fetal Leydig cell hormone production and male genital development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research